Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Cash from Operations (2018 - 2026)

10x Genomics' Cash from Operations history spans 8 years, with the latest figure at 40777000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 704.28% to 40777000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 136050000.0, a 1941.57% increase, with the full-year FY2025 number at 136050000.0, up 1941.57% from a year prior.
  • Cash from Operations hit 40777000.0 in Q4 2025 for 10x Genomics, down from 43214000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for TXG hit a ceiling of 43214000.0 in Q3 2025 and a floor of 26216000.0 in Q3 2021.
  • Historically, Cash from Operations has averaged 3626900.0 across 5 years, with a median of 481000.0 in 2021.
  • Biggest five-year swings in Cash from Operations: crashed 643.69% in 2022 and later surged 704.28% in 2025.
  • Tracing TXG's Cash from Operations over 5 years: stood at 5805000.0 in 2021, then soared by 136.4% to 13723000.0 in 2022, then soared by 87.7% to 25758000.0 in 2023, then crashed by 126.2% to 6748000.0 in 2024, then surged by 704.28% to 40777000.0 in 2025.
  • Business Quant data shows Cash from Operations for TXG at 40777000.0 in Q4 2025, 43214000.0 in Q3 2025, and 17708000.0 in Q2 2025.